inflammation | CARLAT PUBLISHING

Can We Treat Depression by Targeting Inflammation?

September 13, 2021

Christina Guest, MD. Dr. Guest has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

If inflammation plays a role in mood, it makes sense to explore the effects of antibiotics on depression. This study does just that.

EXPERT Q&A

Probiotics in Psychiatry

December 31, 2020

Ted Dinan, MD, PhD

Ted Dinan, MD, PhD
Professor of psychiatry at University College Cork, Ireland. Dr. Dinan’s research focuses on depression, irritable bowel syndrome, and the influence of the gut microbiota on brain function. He has published over 500 scientific papers and numerous books, including 2019’s The Psychobiotic Revolution. Dr. Dinan has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The gut microbiome is one of the newest entries in the list of causes of depression. Ted Dinan explains how the bacteria in the GI tract influence the brain, and whether a probiotic or a lifestyle change is the best way to address it.

EXPERT Q&A

Inflammatory Biomarkers in Depression

February 10, 2020

Andrew H. Miller, MD

Andrew H. Miller, MD

William P. Timmie Professor of Psychiatry and Behavioral Sciences, Emory University, GA Dr. Miller has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Andrew Miller, Vice Chair of Psychiatry Research at Emory University, translates two decades research on inflammation and depression into practical terms, including a low-cost biomarker that may guide antidepressant selection.

Highlights From This Issue

February 10, 2020

Quick hints on what you’ll find in this issue.

Inflammation and Depression: An Interview with Andrew Miller, MD

February 10, 2020

30-50% of patients with depression have signs of inflammation, and some of those markers may help predict which medication they'll respond to. Andrew Miller, MD, of Emory University is one of the leading researchers in this field, and in this interview he tells us when to suspect inflammation and how...

Anti-Inflammatories as Antidepressants?

October 3, 2019

Edmund S. Higgins, MD.

Edmund Higgins, MD Dr. Higgins has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

A host of anti-inflammatory medicines are effective in treatment-resistant depression, particularly celecoxib.